Post Categories
Blog post not found!
How Congress Could Regulate Medicare Drug Prices
December 1, 2021
Prescription drug costs continue to be a concern for many Americans. But now, as Congress works to finalize President Biden’s Build Back Better social…
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
November 15, 2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. The processes for manufacturing therapeutic proteins are not very efficient…
Can Gene Therapy Cure Sickle Cell Disease?
November 8, 2021
Despite being one of the world’s most common inherited blood disorders, sickle cell disease has few treatment options, even with the approval of three…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
